Literature DB >> 16363088

Death or declaw: dealing with moral ambiguity in a veterinary hospital.

Dana Atwood-Harvey1.   

Abstract

The medical practice of declawing has received much political debate over the past few years. Yet, empirical and theoretical research on how this practice is maintained and the ethical positions of those who actually participate in this work is lacking. Drawing from 9 months of ethnographic fieldwork in a feline-specific veterinary hospital and open-ended interviews with veterinarians and staff, this study examines veterinary staff members' attitudes toward, and strategies for, dealing with the medical practice of declawing. Specifically, findings show that a number of staff felt uncomfortable with their participation in onychectomy (declawing) and relied heavily on organizational support structures to cope both with these feelings and the moral ambiguity about the practice. Relying on these structures, the veterinarians and their staff are able simultaneously to define felines as subjects worthy of respect for their quality of life, protect their own self-identity as people who work toward the best interest of animals, and paradoxically support action toward felines that they find morally objectionable.

Entities:  

Keywords:  Bioethics and Professional Ethics; Empirical Approach

Mesh:

Year:  2005        PMID: 16363088     DOI: 10.1163/156853005774653627

Source DB:  PubMed          Journal:  Soc Anim        ISSN: 1063-1119            Impact factor:   0.827


  2 in total

1.  Unwanted Scratching Behavior in Cats: Influence of Management Strategies and Cat and Owner Characteristics.

Authors:  Alissa Cisneros; Dorothy Litwin; Lee Niel; Anastasia C Stellato
Journal:  Animals (Basel)       Date:  2022-09-24       Impact factor: 3.231

2.  Differences in Moral Judgment on Animal and Human Ethics Issues between University Students in Animal-Related, Human Medical and Arts Programs.

Authors:  Joy M Verrinder; Remo Ostini; Clive J C Phillips
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.